Stock listing

A1XFUX Stock Price, News, Filings & Events — Galmed Pharmaceuticals Ltd.

Selected listing: A1XFUX · LS · EUR · DE

This page tracks Galmed Pharmaceuticals Ltd.'s A1XFUX:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1XFUX:LS. A1XFUX:LS is the stock-level entry point for investors researching Galmed Pharmaceuticals Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Galmed Pharmaceuticals Ltd. (Ticker: GLMD) is a public company operating in the American market. The company has a market capitalization of approximately $4.24 million. Galmed focuses on developing innovative therapies for liver diseases and other metabolic disorders.